We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 41 of 59 for:    dry mouth | NIH

Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer (OPTIMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02258659
Recruitment Status : Active, not recruiting
First Posted : October 7, 2014
Last Update Posted : March 9, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2021